KOSPI Breaks 2,300 Level for the First Time in 1 Year and 10 Months... "The Power of Secondary Batteries, Pharmaceuticals, and Bio"

[Asia Economy Reporter Oh Ju-yeon] On the 5th, the domestic stock market closed with a strong performance, rising more than 1%. The KOSPI surpassed the 2300 level for the first time in 1 year and 10 months, and the KOSDAQ index also soared past 840, reaching just below the 850 mark. The driving forces behind the market rise were the secondary battery and pharmaceutical/biotech sectors.

On this day, the KOSPI closed at 2311.86, up 1.40% from the previous trading day, breaking through the 2300 level for the first time in about 1 year and 10 months. The last time the closing price exceeded 2300 was on October 2, 2018, when it reached 2309.57.

On the 4th, the KOSPI index started with an increase of nearly 1%. Dealers are busy working in the Hana Bank dealing room in Euljiro, Seoul. Photo by Moon Honam munonam@

By sector, pharmaceuticals in the KOSPI market rose the most sharply, increasing by 6.33% compared to the previous day. Chemicals (3.74%), non-metallic minerals (3.74%), and textiles/apparel (2.62%) also showed strong gains.

Among the top market capitalization stocks, Samsung Electronics (-0.70%) and SK Hynix (-1.10%) declined, but Samsung Biologics (7.07%) and Celltrion (4.30%) closed higher. Notably, the stock prices of secondary battery-related companies among the top market cap stocks showed remarkable increases.

LG Chem (4.36%) and Samsung SDI (12.50%) surged significantly, hitting new intraday highs. LG Chem rose to 681,000 KRW during the session, and Samsung SDI closed at a 52-week high of 468,000 KRW.

In terms of trading volume, individual investors were net buyers of 429.8 billion KRW, while foreigners and institutions were net sellers of 45.6 billion KRW and 364 billion KRW, respectively.

The KOSDAQ index comfortably surpassed the 840 level, closing up 1.43% at 847.28 compared to the previous trading day.

Among the top market cap stocks, Celltrion Healthcare (5.85%) posted the largest gain, while Seegene (0.58%), HL Biopharma (3.64%), Celltrion Pharm (4.72%), and EcoPro BM (5.23%) also rose significantly.

In the KOSDAQ market, individual investors were net sellers of 115.6 billion KRW, whereas foreigners and institutions were net buyers of 101.7 billion KRW and 32.8 billion KRW, respectively.

Lee Kyung-min, a researcher at Daishin Securities, analyzed, "The core of the KOSPI's recovery to 2300 lies in the secondary battery and pharmaceutical/biotech sectors."

Lee explained, "In the additional upward phase of the KOSPI, if the rotation was previously from value stocks to growth stocks and from leading stocks to neglected stocks, with the inflow of foreign net buying, rotation is now occurring within growth and leading stocks. The KOSPI's rise is continuing with fluctuations within the semiconductor, internet, secondary battery, pharmaceutical/biotech, and automobile sectors."

This content was produced with the assistance of AI translation services.